• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

急性冠状动脉综合征的综合风险评分

Composite risk scores for acute coronary syndromes.

作者信息

Chandra K Sarat

出版信息

Indian Heart J. 2012 May-Jun;64(3):270-2. doi: 10.1016/S0019-4832(12)60085-6.

DOI:10.1016/S0019-4832(12)60085-6
PMID:22664809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3861005/
Abstract

There have been considerable advances in the management of acute coronary syndromes in the recent past. There are three risk scoring systems used for prognosticating these patients. An attempt is made in this article to discuss the pros and cons of the different risk scoring systems and their clinical utility.

摘要

近年来，急性冠状动脉综合征的管理取得了相当大的进展。有三种风险评分系统用于对这些患者进行预后评估。本文试图讨论不同风险评分系统的优缺点及其临床实用性。

相似文献

1
Composite risk scores for acute coronary syndromes.急性冠状动脉综合征的综合风险评分
Indian Heart J. 2012 May-Jun;64(3):270-2. doi: 10.1016/S0019-4832(12)60085-6.
2
Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.急性冠状动脉综合征患者中RISK-PCI、GRACE、TIMI风险评分对主要不良心脏事件预测的比较。
Croat Med J. 2017 Dec 31;58(6):406-415. doi: 10.3325/cmj.2017.58.406.
3
Utility of 3D-OCT Imaging With Angiographic Co-Registration in Acute Coronary Syndrome With Normal or Near-Normal Coronary Arteries.三维光学相干断层扫描成像与血管造影共配准在冠状动脉正常或接近正常的急性冠状动脉综合征中的应用价值。
J Invasive Cardiol. 2017 Jul;29(7):E84-E85.
4
"Mind the gap" acute coronary syndrome in women: A contemporary review of current clinical evidence.女性“留意差距”急性冠状动脉综合征：当前临床证据的当代综述
Int J Cardiol. 2017 Jan 15;227:840-849. doi: 10.1016/j.ijcard.2016.10.020. Epub 2016 Oct 11.
5
The year in cardiology 2013: acute coronary syndromes.2013 年心脏病学年鉴：急性冠脉综合征。
Eur Heart J. 2014 Feb;35(6):349-52. doi: 10.1093/eurheartj/eht548. Epub 2014 Jan 2.
6
CHA2DS2-VASc and R2CHA2DS2-VASc scores have predictive value in patients with acute coronary syndromes.CHA2DS2-VASc评分和R2CHA2DS2-VASc评分在急性冠脉综合征患者中具有预测价值。
Pol Arch Med Wewn. 2015;125(7-8):545-52. doi: 10.20452/pamw.2965. Epub 2015 Jul 15.
7
Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study.入院时、出院时及1个月后测量C反应蛋白以预测急性冠状动脉疾病患者预后的临床效用。RISCA（急性冠状动脉综合征中的复发和炎症）研究。
J Am Coll Cardiol. 2008 Jun 17;51(24):2339-46. doi: 10.1016/j.jacc.2008.03.019.
8
Acute coronary syndrome as the first manifestation of essential thrombocythaemia: A challenge for cardiologists.急性冠状动脉综合征作为原发性血小板增多症的首发表现：对心脏病专家的一项挑战。
Clin Investig Arterioscler. 2020 May-Jun;32(3):126-128. doi: 10.1016/j.arteri.2019.10.007. Epub 2020 Jan 21.
9
Prediction of acute coronary syndromes by urinary proteome analysis.通过尿液蛋白质组分析预测急性冠状动脉综合征
PLoS One. 2017 Mar 8;12(3):e0172036. doi: 10.1371/journal.pone.0172036. eCollection 2017.
10
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE score.采用 hsTnT、NT-proBNP 和 hsCRP 联合 GRACE 评分对急性冠脉综合征患者进行改良危险分层。
Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):129-138. doi: 10.1177/2048872616684678. Epub 2016 Dec 28.

本文引用的文献

1
Validation of the GRACE score for prognosis in Indian patients with acute coronary syndromes.GRACE评分对印度急性冠脉综合征患者预后的验证
Indian Heart J. 2012 May-Jun;64(3):263-9. doi: 10.1016/S0019-4832(12)60084-4.
2
Early versus delayed invasive intervention in acute coronary syndromes.急性冠状动脉综合征的早期与延迟侵入性干预
N Engl J Med. 2009 May 21;360(21):2165-75. doi: 10.1056/NEJMoa0807986.
3
TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.TIMI、PURSUIT和GRACE风险评分：非ST段抬高型急性冠脉综合征中的持续预后价值及与血运重建的相互作用
Eur Heart J. 2005 May;26(9):865-72. doi: 10.1093/eurheartj/ehi187. Epub 2005 Mar 11.
4
Predictors of hospital mortality in the global registry of acute coronary events.全球急性冠状动脉事件注册研究中院内死亡的预测因素。
Arch Intern Med. 2003 Oct 27;163(19):2345-53. doi: 10.1001/archinte.163.19.2345.
5
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.不稳定型冠状动脉综合征患者干预前延长抗血栓预处理（“冷静期”策略）的评估：一项随机对照试验。
JAMA. 2003 Sep 24;290(12):1593-9. doi: 10.1001/jama.290.12.1593.
6
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.使用糖蛋白IIb/IIIa抑制剂替罗非班治疗的不稳定型冠状动脉综合征患者早期侵入性策略与保守策略的比较
N Engl J Med. 2001 Jun 21;344(25):1879-87. doi: 10.1056/NEJM200106213442501.
7
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.非持续性ST段抬高急性冠脉综合征患者预后的预测因素。一项针对9461例患者的国际试验结果。PURSUIT研究组
Circulation. 2000 Jun 6;101(22):2557-67. doi: 10.1161/01.cir.101.22.2557.
8
TIMI 11B. Enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial. Rationale, study design, and methods. Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators.心肌梗死溶栓治疗（TIMI）11B研究。依诺肝素与普通肝素治疗不稳定型心绞痛或非Q波心肌梗死的双盲、安慰剂对照、平行组、多中心试验。原理、研究设计与方法。心肌梗死溶栓治疗（TIMI）11B试验研究者。
Am Heart J. 1998 Jun;135(6 Pt 3 Su):S353-60. doi: 10.1016/s0002-8703(98)70265-0.